hotspot -WSS

hotspot

author：explore 2025-09-14 08:28:58 - browse：5937

Adobe

The medical device industry is split on whether a proposed new Medicare reimbursement pathway will do anything to soothe their insurance coverage woes.

Device makers have long complained that the unclear, rocky road to payment kills innovative companies. So they were thrilled when the Trump administration proposed a rule that would have guaranteed four years of Medicare coverage of approved devices deemed “breakthroughs” by the Food and Drug Administration. They hoped private payers would follow suit. But in 2021, under a new administration and a push for more device scrutiny, the Centers for Medicare and Medicaid pulled back on the idea, promising a replacement that would streamline coverage for innovative devices while ensuring safe, high-quality care.

The pathway put forth last week, called Transitional Coverage for Emerging Technologies (TCET), is only a notice, not yet a rule that would grant CMS new powers. The program applies solely to devices that have earned a place in the FDA’s breakthrough device program, which was established to identify devices that the agency believed could provide “more effective” treatment or diagnosis of serious conditions than the current standard of care. But because those devices can be brought to market with less certainty in their benefits and risks than other products, experts said, the idea of automatic reimbursement was dicey.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： A new approach to psychiatric drug development

WSS

The public health thinking behind the CDC’s new Covid guidance

European officials brace for rough respiratory virus season

State of the Union pitch: Bigger Medicare drug price negotiations

Flu, Covid vaccination rates decline, new survey data show

The Karikó problem: Lessons for funding basic research

Stem cell biologist probes earliest stages of human development

hotspot

hotspot

knowledge

Heart attack and stroke risk calculators need revising

IVG is promising — but it won’t replace IVF quite yet

DIEP, the 'gold standard' of breast reconstruction, is under threat

6 solutions to address cancer drug shortages and others

Wildfire smoke exposes gaps in outdoor worker protections

Microsoft's Peter Lee: Generative AI could help doctors be more human

Medical records are filled with copy

First over

Duchenne breakthrough therapy leaves behind pioneering families

What will Novo Nordisk's VC do with its influx of cash?

hotspot

Lawsuit highlights wrinkle for disputes over surprise medical bills

$1 billion proposal to grow Boston, Massachusetts biotech

For AI in health care standards, federal regulators join with industry group

What will Novo Nordisk's VC do with its influx of cash?

For AI in health care standards, federal regulators join with industry group

With Roe v Wade overturned, abortion providers work to adapt

hotspot

focus

knowledge

leisure time